Literature DB >> 11161378

Chromosomal changes during development and progression of prostate adenocarcinomas.

H Zitzelsberger1, D Engert, A Walch, U Kulka, M Aubele, H Höfler, M Bauchinger, M Werner.   

Abstract

Chromosomal copy number changes were investigated in 16 prostate carcinomas, 12 prostatic intraepithelial neoplasias (PIN; 4 low-grade and 8 high-grade) adjacent to the invasive tumour areas, and 5 regional lymph node metastases. For this purpose, comparative genomic hybridization (CGH) was performed and a copy number karyotype for each histomorphological entity was created. CGH on microdissected cells from non-neoplastic glands was carried out on 3 different cases to demonstrate the reliability of the overall procedure. None of the non-neoplastic tissue samples revealed chromosome copy number changes. In PIN areas, chromosomal imbalances were detected on chromosomes 7, 8q, Xq (gains), and on 4q, 5q, 8p, 13q and 18q (losses). In the primary tumours, recurrent (at least 25% of cases) gains on chromosomes 12q and 15q, and losses on 2q, 4q, 5q, Xq, 13q and 18q became apparent. Losses on 8p and 6q as well as gains on 8q and of chromosome 7 were also detected at lower frequencies than previously reported. The pooled CGH data from the primary carcinomas revealed a novel region of chromosomal loss on 4q which is also frequently affected in other tumour entities like oesophageal adenocarcinomas and is supposed to harbour a new tumour suppressor gene. Gains on chromosome 9q and of chromosome 16 and loss on chromosome 13q were observed as common aberrations in metastases and primary tumours. These CGH results indicate an accumulation of chromosomal imbalances during the PIN-carcinoma-metastasis sequence and an early origin of tumour-specific aberrations in PIN areas. Copyright 2001 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11161378      PMCID: PMC2363712          DOI: 10.1054/bjoc.2000.1533

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  38 in total

1.  Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.

Authors:  D F Gleason; G T Mellinger
Journal:  J Urol       Date:  1974-01       Impact factor: 7.450

2.  Extensive ductal carcinoma In situ with small foci of invasive ductal carcinoma: evidence of genetic resemblance by CGH.

Authors:  M Aubele; A Mattis; H Zitzelsberger; A Walch; M Kremer; G Welzl; H Höfler; M Werner
Journal:  Int J Cancer       Date:  2000-01-01       Impact factor: 7.396

3.  Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer.

Authors:  M M Aubele; M C Cummings; A E Mattis; H F Zitzelsberger; A K Walch; M Kremer; H Höfler; M Werner
Journal:  Diagn Mol Pathol       Date:  2000-03

4.  Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization.

Authors:  S Solinas-Toldo; C Wallrapp; F Müller-Pillasch; M Bentz; T Gress; P Lichter
Journal:  Cancer Res       Date:  1996-08-15       Impact factor: 12.701

5.  Evaluation of 20 archival prostate tumor specimens by fluorescence in situ hybridization (FISH).

Authors:  A R Brothman; M J Watson; X L Zhu; B J Williams; L R Rohr
Journal:  Cancer Genet Cytogenet       Date:  1994-07-01

6.  Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer.

Authors:  J A Macoska; T M Trybus; W A Sakr; M C Wolf; P D Benson; I J Powell; J E Pontes
Journal:  Cancer Res       Date:  1994-07-15       Impact factor: 12.701

7.  Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.

Authors:  A Kallioniemi; O P Kallioniemi; D Sudar; D Rutovitz; J W Gray; F Waldman; D Pinkel
Journal:  Science       Date:  1992-10-30       Impact factor: 47.728

8.  In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors.

Authors:  A H Hopman; F C Ramaekers; A K Raap; J L Beck; P Devilee; M van der Ploeg; G P Vooijs
Journal:  Histochemistry       Date:  1988

9.  Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization.

Authors:  S du Manoir; M R Speicher; S Joos; E Schröck; S Popp; H Döhner; G Kovacs; M Robert-Nicoud; P Lichter; T Cremer
Journal:  Hum Genet       Date:  1993-02       Impact factor: 4.132

10.  Prostatic intra-epithelial neoplasia and early invasion in prostate cancer.

Authors:  D G Bostwick; M K Brawer
Journal:  Cancer       Date:  1987-02-15       Impact factor: 6.860

View more
  19 in total

Review 1.  Molecular mechanisms involving prostate cancer racial disparity.

Authors:  Cansu Karakas; Cassie Wang; Fangming Deng; Hongying Huang; Dongwen Wang; Peng Lee
Journal:  Am J Clin Exp Urol       Date:  2017-11-09

2.  Simultaneous tumour-like, atypical basal cell hyperplasia and acinar adenocarcinoma of the prostate: a comparative morphological and genetic approach.

Authors:  A M Luebke; T Schlomm; B Gunawan; H Bonkhoff; L Füzesi; A Erbersdobler
Journal:  Virchows Arch       Date:  2005-02-22       Impact factor: 4.064

3.  Genomic profiling of hormone-naïve lymph node metastases in patients with prostate cancer.

Authors:  Pamela L Paris; Matthias D Hofer; Giancarlo Albo; Rainer Kuefer; Juergen E Gschwend; Richard E Hautmann; Jane Fridyland; Jeffrey Simko; Peter R Carroll; Mark A Rubin; Colin Collins
Journal:  Neoplasia       Date:  2006-12       Impact factor: 5.715

4.  Identification of a gene frequently mutated in prostate tumors.

Authors:  D J Reding; K Q Zhang; S A Salzman; J V Thomalla; R E Riepe; B K Suarez; W J Catalona; J K Burmester
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

5.  Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas.

Authors:  Silke Lassmann; Roland Weis; Frank Makowiec; Jasmine Roth; Mihai Danciu; Ulrich Hopt; Martin Werner
Journal:  J Mol Med (Berl)       Date:  2006-12-02       Impact factor: 4.599

6.  CYP24A1 is an independent prognostic marker of survival in patients with lung adenocarcinoma.

Authors:  Guoan Chen; So Hee Kim; Amanda N King; Lili Zhao; Robert U Simpson; Paul J Christensen; Zhuwen Wang; Dafydd G Thomas; Thomas J Giordano; Lin Lin; Dean E Brenner; David G Beer; Nithya Ramnath
Journal:  Clin Cancer Res       Date:  2010-12-17       Impact factor: 12.531

7.  Relationship between ABO blood groups and carcinoma of esophagus and cardia in Chaoshan inhabitants of China.

Authors:  M Su; S M Lu; D P Tian; H Zhao; X Y Li; D R Li; Z C Zheng
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

8.  Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancer.

Authors:  Sharanjot Saini; Shahana Majid; Varahram Shahryari; Z Laura Tabatabai; Sumit Arora; Soichiro Yamamura; Yuichiro Tanaka; Rajvir Dahiya; Guoren Deng
Journal:  Mol Cancer Ther       Date:  2014-05-09       Impact factor: 6.261

9.  The candidate oncogene CYP24A1: A potential biomarker for colorectal tumorigenesis.

Authors:  Henrik C Horváth; Péter Lakatos; János P Kósa; Krisztián Bácsi; Katalin Borka; Giovanna Bises; Thomas Nittke; Pamela A Hershberger; Gábor Speer; Enikö Kállay
Journal:  J Histochem Cytochem       Date:  2009-11-09       Impact factor: 2.479

10.  Molecular mechanisms involving prostate cancer racial disparity.

Authors:  David Hatcher; Garrett Daniels; Iman Osman; Peng Lee
Journal:  Am J Transl Res       Date:  2009-04-20       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.